Vaccination News Home Page subscribe Vaccination NewsLetter
|
|
|||
|
|
|
|
|
|
|
|
1 of 1 |
|
Mechanisms of Ageing and Development
Volume 124, Issue 5 , May 2003, Pages 679-696
| This Document | ||
|
|
Abstract | |
| Full Text + Links | ||
| PDF (670 K) | ||
| Actions | ||
| E-mail Article | ||
![]()
doi:10.1016/S0047-6374(03)00063-0
Cite
or link using doi
Copyright © 2003 Elsevier Science Ireland Ltd. All rights
reserved.
Analysis of mortality decline along with age and latent congenital defects
Mortality from congenital anomalies is inversely proportional to age after the age of 1 year. The theory of congenital individual risk explains this mortality decline. The overall aim of this study is to test whether the theory describes mortality decline for all diseases within the first year of life and after the age of 1. Mortality decline along with age was analyzed in five countries and for all causes of death. The theory of congenital individual risk describes well the real mortality decline for all diseases except malignant neoplasms after the birth. Decline of mortality is due to the dying out of the more impaired individuals. Mortality decline with the first power of age results from the selection before the birth. It is dominant and the frequency of defects decreases proportionally to the value of individual risk of death. In the case of identically probable defects, the selection does not occur and mortality declines with the square of age. Congenital defects were also identified as a cause of death in the case of infectious diseases occurring before the age of 10. Mortality from malignant neoplasms is age-independent within the age period 1–20 years and, contrary to all other diseases, no small subpopulation with a significant individual risk was identified.
Author Keywords: Mortality; Age; Congenital anomaly;
Infectious diseases; Theory of congenital individual risk
|
|
|||||||||||||||||||||||||
Mechanisms of Ageing and Development |
|||||||||||||||||||||||||
|
|
|
1 of 1 |
|
|
|
|
|
|
| Send
feedback to ScienceDirect Software and compilation © 2003 ScienceDirect. All rights reserved. ScienceDirect® is an Elsevier Science B.V. registered trademark. |
Your use of this service is
governed by
Terms and Conditions. Please review our
Privacy Policy for details on how we protect information that you supply.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.